+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis

Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis

Scandinavian Journal of Gastroenterology 52(3): 321-327

In autoimmune hepatitis, data on the prognostic value of baseline liver biopsy and the sequential histology is controversial. Our aim was to evaluate the prognostic value of clinical variables and biopsy at the time of diagnosis and during the disease course. All 98 patients in our hospital during 1995-2012 were included. Sequential biopsies were available in 66 patients. Analyses based on clinical and histological variables were performed to find parameters predicting the progression of fibrosis, and development of cirrhosis. At the time of diagnosis, 7% were cirrhotic. Fibrosis progressed in 28 (42%) patients, remained stable in 26 (39%) and resolved in 12 (18%) patients. Findings which predicted fibrosis progression, were baseline total inflammation (odds ratio 1.7, 95% CI 1.01-2.8), cumulative total inflammation (1.8, 95% CI 1.01-3.2, rosette formation (2.8, 95% CI 1.1-7.1), absence of pericholangitis (0.4, 95% CI 0.1-1.0) and necrosis (1.4, 95% CI 1.0-2.0). Risk factors for the development of cirrhosis were cholestasis (4.6, 95% CI 1.2-16.9), interphase inflammation (3.4, 95% CI 1.1-10.4), and necrosis (3.3, 95% CI 1.2-9.7). In a cumulative model, cumulative total inflammation (4.5, 95% CI 1.4-15.0), necrosis (6.7, 95% CI 1.3-34.6), or cumulative immunoglobulin G load (61.8, 95% CI 2.0-1954.3) were risk factors. None of the patients with histological pericholangitis or granulomas developed cirrhosis. The histology provides prognostic information regarding progression of fibrosis or the development of cirrhosis. The total cumulative inflammatory activity predicts the progression of fibrosis, whereas baseline fibrosis, interphase inflammation, cholestasis, necrosis, as well as the cumulative total inflammation and cumulative immunoglobulin G, are risk factors for cirrhosis.

(PDF emailed within 0-6 h: $19.90)

Accession: 058637687

Download citation: RISBibTeXText

PMID: 27846740

DOI: 10.1080/00365521.2016.1253768

Related references

Simple clinical variables predict liver histology in hepatitis C: prospective validation of a clinical prediction model. Scandinavian Journal of Gastroenterology 40(11): 1365-1371, 2005

Simple clinical variables predict liver histology in hepatitis c prospective validation of a clinical prediction model. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M1428, 2003

Transient Elastography (FibroScan) Performs Better Than Non-Invasive Markers in Assessing Liver Fibrosis and Cirrhosis in Autoimmune Hepatitis Patients. Medical Science Monitor 23: 5106-5112, 2018

Clinical and prognostic value of quantified fibrosis in alcoholic liver cirrhosis. Revista Espanola de las Enfermedades del Aparato Digestivo 68(5): 413-419, 1985

Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis. Hepatology Research 38(8): 784-789, 2008

Living donor liver transplantation for autoimmune hepatitis and autoimmune hepatitis-primary biliary cirrhosis overlap syndrome. 2012

Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology 30(1): 53-57, 1999

Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study. Hepatology Research 39(6): 577-584, 2009

A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection. Plos One 12(5): E0176282, 2017

Utility of real-time shear wave elastography for assessing liver fibrosis in patients with chronic hepatitis C infection without cirrhosis: Comparison of liver fibrosis indices. Hepatology Research 45(10): E122-E129, 2015

Sequential development of acute autoimmune hepatitis may lead to a serious clinical picture in primary biliary cirrhosis. European Journal of Gastroenterology and Hepatology 27(10): 1228-1229, 2015

"Overlap" syndromes. Autoimmune hepatitis--primary biliary liver cirrhosis; autoimmune hepatitis--primary sclerosing cholangitis. Presse Medicale 30(1): 25-27, 2001

Autoimmune diseases of the liver, autoimmune hepatitis and primary biliary cirrhosis: Unfinished business. Hepatology Research 37 Suppl 3: S357-S364, 2007

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. Journal of Autoimmune Diseases 4: 3, 2007

A case of autoimmune hepatitis needed to be differentiated from EBV hepatitis, in that the histology of liver biopsy specimen was useful for diagnosis. Nihon Rinsho Men'eki Gakkai Kaishi 28(3): 154-158, 2005